Combretastatin
Showing 1 - 22 of 22
Acute Myelogenous Leukemia, MDS Trial in United States (Phase 1 - OXi4503, Phase 1 - OXi4503 + cytarabine, Phase 2 - OXi4503 +
Unknown status
- Acute Myelogenous Leukemia
- Myelodysplastic Syndromes
- Phase 1 - OXi4503
- +2 more
-
Los Angeles, California
- +3 more
Jun 1, 2018
Combretastatin A4 Phosphate, Age-related Macular Degeneration, AMD Trial in Baltimore (Combretastatin A-4 phosphate,
Completed
- Combretastatin A4 Phosphate
- +4 more
- Combretastatin A-4 phosphate
- Combretastatin A-4 Phosphate
-
Baltimore, MarylandWilmer Eye Institute
Dec 4, 2017
Colorectal Cancer, Solid Tumor Trial in Seoul (CKD-516 plus Durvalumab)
Recruiting
- Colorectal Cancer
- Solid Tumor
- CKD-516 plus Durvalumab
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Feb 24, 2021
Leukemia, Myelogenous, Acute, MDS Trial in Gainesville (OXi4503)
Terminated
- Leukemia, Myelogenous, Acute
- Myelodysplastic Syndromes
-
Gainesville, FloridaUF Health Shands Cancer Hopsital
Aug 7, 2017
Neuroendocrine Tumors Trial in United States (fosbretabulin tromethamine)
Completed
- Neuroendocrine Tumors
- fosbretabulin tromethamine
-
Stanford, California
- +4 more
Oct 31, 2017
Platinum Resistant Ovarian Cancer Trial in Belgium, Germany, United States (Fosbretabulin tromethamine, Placebo)
Terminated
- Platinum Resistant Ovarian Cancer
- Fosbretabulin tromethamine
- Placebo
-
Birmingham, Alabama
- +39 more
Mar 20, 2018
Peptide-drug-conjugates for Personalized, Targeted Therapy of
Unknown status
- CLL
- there will be no intervention.
- (no location specified)
Jul 7, 2016
Solid Tumor, Anaplastic Thyroid Cancer Trial run by the NCI (Crolibulin, Cisplatin)
Completed
- Solid Tumor
- Anaplastic Thyroid Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 27, 2017
Sarcoma Trial in Worldwide (OMBRABULIN (AVE8062), Placebo)
Completed
- Sarcoma
- OMBRABULIN (AVE8062)
- Placebo
-
Santa Monica, California
- +44 more
Nov 18, 2015
Anaplastic Thyroid Cancer Trial in Worldwide (CA4P, paclitaxel, carboplatin)
Anaplastic Thyroid Cancer Trial (Fosbretabulin + paclitaxel + carboplatin, Placebo + paclitaxel + carboplatin)
Withdrawn
- Anaplastic Thyroid Cancer
- Fosbretabulin + paclitaxel + carboplatin
- Placebo + paclitaxel + carboplatin
- (no location specified)
Apr 30, 2014
Solid Tumor Trial in Cleveland (fosbretabulin disodium)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- fosbretabulin disodium
-
Cleveland, OhioIreland Cancer Center
Jan 6, 2014
Solid Tumor Trial in Northwood (fosbretabulin disodium)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- fosbretabulin disodium
-
Northwood, England, United KingdomMount Vernon Hospital
Dec 18, 2013
Choroidal Neovascularization, Myopia, Degenerative Trial (Combretastatin A-4 Phosphate)
Completed
- Choroidal Neovascularization
- Myopia, Degenerative
- Combretastatin A-4 Phosphate
- (no location specified)
Oct 28, 2011
Cancer, Tumor Trial in Salt Lake City (Combretastatin A-4 Phosphate + Paclitaxel + Carboplatin)
Completed
- Cancer
- Tumor
- Combretastatin A-4 Phosphate + Paclitaxel + Carboplatin
-
Salt Lake City, UtahHuntsman Cancer Institute
Oct 28, 2011
Tumors Trial in Northwood, Sutton (Combretastatin A4 Phosphate (CA4P), Bevacizumab (Avastin))
Completed
- Tumors
- Combretastatin A4 Phosphate (CA4P)
- Bevacizumab (Avastin)
-
Northwood, Middlesex, United Kingdom
- +1 more
Oct 28, 2011
Polypoidal Choroidal Vasculopathy Trial in Worldwide (fosbretabulin, Saline)
Completed
- Polypoidal Choroidal Vasculopathy
-
Los Angeles, California
- +4 more
Oct 28, 2011
Tumor Metastasis Trial in Australia (Combretastatin A1 Diphosphate (OXi4503))
Completed
- Neoplasm Metastasis
- Combretastatin A1 Diphosphate (OXi4503)
-
Westmead, New South Wales, Australia
- +3 more
Aug 22, 2011
Head Neck Cancer Trial in Detroit, Cleveland, Pittsburgh (fosbretabulin disodium)
Completed
- Head and Neck Cancer
- fosbretabulin disodium
-
Detroit, Michigan
- +2 more
Jun 10, 2010
Head Neck Cancer Trial in Detroit, Cleveland, Pittsburgh (biological, drug, radiation)
Terminated
- Head and Neck Cancer
- filgrastim
- +5 more
-
Detroit, Michigan
- +2 more
Jun 9, 2010